Quality Use of Medicines in People Living with Dementia Top 10 Priorities

  1. How can shared decision making about medicines be achieved between healthcare professionals and people living with dementia and their carers?
  2. What are effective ways to ensure that healthcare professionals have the necessary knowledge and skills to achieve safe effective and appropriate medication use in people living with dementia?
  3. How can communication between healthcare professionals be optimised, especially at transitions of care, to achieve multi-disciplinary care for people living with dementia?
  4. Which medicines are potentially harmful or unnecessary in people living with dementia and should be stopped? And how can deprescribing (cessation of harmful and/or unnecessary medicines) be achieved in people living with dementia?
  5. When, how and in who should medicines be used to manage pain in people living with dementia?
  6. How can people living with dementia and their carers be supported to manage medicines safely at home?
  7. When and how should medicines be used to treat changed behaviours (previously referred to as behavioural and psychological symptoms of dementia)? Including for different types of dementia. And how to safely and effectively reduce the use of antipsychotics (for changed behaviours) in people living with dementia?
  8. How can residential aged care facilities best achieve safe, effective and appropriate medicine use in residents with dementia?
  9. When, how and in who should medicines be used to treat depression and anxiety in people living with dementia?
  10. What is the optimal model for medicine reviews to achieve safe, effective and appropriate medicine use in people living with dementia? Including who should be involved, how often should reviews be conducted, and what follow-up is needed?